Dow Down0.02% Nasdaq Up0.07%

Catalyst Pharmaceutical Partners Inc. (CPRX)

2.73 0.02(0.74%) Nov 25, 4:00PM EST
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.0
Mean Recommendation (last week):2.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:7.00
Median Target:6.00
High Target:13.00
Low Target:4.00
No. of Brokers:5

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Sep 24, 2013Maxim GroupInitiated Buy
Apr 18, 2013Aegis CapitalInitiated Buy
Aug 27, 2012Rodman & RenshawUpgradeMkt PerformMkt Outperform
Oct 1, 2009MerrimanUpgradeSellNeutral
May 29, 2009Merriman Curhan FordDowngradeBuySell
May 29, 2009HapoalimDowngradeNeutralUnderperform
Dec 15, 2008Merriman Curhan FordInitiated Buy
Nov 28, 2007Rodman & RenshawInitiated Mkt Outperform
Jan 31, 2007Stifel NicolausInitiated Buy
Jan 5, 2007First AlbanyInitiated Buy
Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0000

Data provided by Thomson/First Call

Currency in USD.